Brazil reports 16,282 daily confirmed cases of COVID-19
330 more people have died from coronavirus in Brazil over the past 24 hours, bringing the country’s death toll from the virus to 136,895.
Brazil is the third-hardest hit by the virus worldwide after the United States and India.
The number of confirmed cases has reached 4,544,629 in the country, an increase of 16,282 cases in the last 24 hours.
While at least 8,318 patients are being treated in intensive care units, more than 3,851,227 patients suffering from coronavirus have fully recovered and been discharged from hospital.
So far, at least 15,011,116 tests have been conducted to detect infections in the country.
Sao Paulo, the country’s most-populated state, continues to be the epicenter of the coronavirus pandemic in Brazil.
The state has so far reported more than 935,000 confirmed coronavirus cases, with at least 33,952 deaths. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
Any European Union defense structure must complement NATO rather than create a parallel system that would drain resources and weaken collective security, NATO’s Supreme Allied Commander Europe (SACEUR), U.S. Air Force Gen. Alexus Grynkewich, told lawmakers on Monday.
Turkish Foreign Minister Hakan Fidan met with United Arab Emirates President Sheikh Mohamed bin Zayed Al Nahyan in Abu Dhabi to discuss bilateral relations and opportunities to further strengthen cooperation between Türkiye and the UAE.
More than 1,700 Israeli settlers defiled the Al-Aqsa Mosque compound in occupied East Jerusalem on Monday under heavy Israeli police protection, as incursions intensified during the Jewish Sukkot holiday.
The Council of the European Union has adopted new rules introducing comprehensive changes to the bloc's pharmaceutical legislation, aiming to improve patients' access to safe, effective and affordable medicines while supporting innovation in the pharmaceutical sector.